Drug Database
Back to search

Switzerland· 49999453

Optiray 350, Injektionslösung

A ioversol product containing iodum, registered in Switzerland by Guerbet AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC V08AB07

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedOptiray 350, InjektionslösungATCV08AB07REGISTER NO.49999453PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about iodumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ioversol is registered in 14 of 19 countries.

Countries holding a registration under ATC V08AB07 (ioversol), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 7 of them publish a price we can compare per daily dose
Search ioversol products by name

Ioversol · ATC V08AB07

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
iodum
Manufacturer
Guerbet AG
Country
Switzerland (CH)
ATC code
V08AB07
ATC class
Ioversol
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680499994535
    Durchstf 100 ml
    CHF 67.5

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

188 interactions on record for ioversol.

Graded by severity as the source publishes them — 94 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ioversol against other medicinesHow interaction checks work

Ioversol · interactions on record

188 records

  • 94 severe
  • 55 moderate
  • 39 info

Most severe, free to view

  • NeomycinA07AA01severe
  • StreptomycinA07AA04severe
  • Polymyxin BA07AA05severe
  • Amphotericin BA07AA07severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ioversol in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ioversol products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Bulgaria · Етанолов Разтвор На Йод Bt, Етанолов Разтвор На Йод Купро
  • Czechia · Lipiodol Ultra Fluide
  • Germany · Iod Caelo
  • Denmark · Omnipaque
  • Estonia · Iodine Valentis, Solutio Iodi Spirituosa
  • Spain · Tintura De Yodo Laboratorios Reig Jofré S.A.
  • Greece · Βαμμα Ιωδιου Mediplants, Βαμμα Ιωδιου Ζαρμπη
  • Croatia · Jod B. Braun
  • Lithuania · Jodas Bp, Jodas Valentis
  • Latvia · Joda Šķīdums Valentis, Joda Spirta Šķīdums
  • Poland · Jodid, Jodyna

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b73ee54c-79f3-4229-a13f-68bdf7957d0f
GET /v1/drugs/b73ee54c-79f3-4229-a13f-68bdf7957d0f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "ioversolum 742 mg",
  "valid_from": "1994-03-15",
  "limitations": null,
  "galenic_form": "Inj Lös 350 mg/ml",
  "therapeutic_area": null,
  "sl_inclusion_date": "1994-03-15",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about ioversol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console